Ignite Creation Date:
2024-05-06 @ 2:00 PM
Last Modification Date:
2024-10-26 @ 1:23 PM
Study NCT ID:
NCT04182568
Status:
UNKNOWN
Last Update Posted:
2019-12-02
First Post:
2019-11-27
Brief Title:
Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer
Sponsor:
Xijing Hospital
Organization:
Xijing Hospital
Organization Data
Organization:
Xijing Hospital
Class:
OTHER
Study ID:
KY20192081-F-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xijing Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None